Sale!

Pre-eclampsia Screening Panel Test

700 د.إ

-10%

Pre-eclampsia is a potentially dangerous pregnancy complication characterized by high blood pressure and signs of damage to another organ system, most often the liver and kidneys. It usually begins after 20 weeks of pregnancy in women whose blood pressure had been normal. Left untreated, pre-eclampsia can lead to serious — even fatal — complications for both the mother and baby.

The Pre-eclampsia Screening Panel Test is a vital tool in the early detection and management of this condition. It typically involves a combination of blood tests and ultrasound assessments to evaluate the risk of pre-eclampsia. These tests look for specific markers in the blood that are associated with an increased risk of developing pre-eclampsia and assess the blood flow to the placenta.

At DNA Labs UAE, a comprehensive Pre-eclampsia Screening Panel Test is available for expectant mothers. The cost of the test is 700 AED. Conducting this test at DNA Labs UAE ensures that you receive accurate and reliable results, thanks to their state-of-the-art facilities and experienced medical professionals. Early detection through this screening panel can lead to timely intervention, significantly reducing the risk of complications associated with pre-eclampsia, and ensuring a safer pregnancy journey.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PRE-ECLAMPSIA SCREENING PANEL Test

Components:

  • Placental Growth Factor (PlGF)
  • Pregnancy Associated Plasma Protein A (PAPP-A)

Price: 700.0 AED

Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Test is valid between 10-13 weeks gestation. It is mandatory to provide maternal Date of birth (dd/mm/yy); Height, weight, IVF, Smoking, History of blood pressure, Diabetes and Pre-eclampsia in previous pregnancy, Number of Fetuses (Single/Twins); Blood pressure measurement for right & left arm; USG for CRL & Uterine artery PI. Duly filled Pre-eclampsia screening form (Form 13) is mandatory.

Report Delivery: Sample Tue / Thu / Sat by 9 am

Report Same Day

Method: ECLIA

Test type: Pre-eclampsia

Doctor: Gynecologist

Test Department: IMMUNOASSAY

Pre Test Information: Duly filled Pre-eclampsia screening form (Form 13) is mandatory. Test is valid between 10-13 weeks gestation.

Test Details

The pre-eclampsia screening panel is a set of tests conducted during pregnancy to assess the risk of developing pre-eclampsia, a condition characterized by high blood pressure and organ damage during pregnancy. The panel typically includes the following tests:

  1. Blood Pressure Measurement: This is a standard test to monitor blood pressure levels throughout pregnancy. High blood pressure is one of the main symptoms of pre-eclampsia.
  2. Urine Protein Test: This test measures the amount of protein present in the urine. Increased protein levels can indicate kidney damage, which is a common sign of pre-eclampsia.
  3. Blood Tests: Various blood tests may be performed to evaluate liver and kidney function, as well as to assess blood clotting factors. Abnormalities in these tests can indicate pre-eclampsia.
  4. Ultrasound: An ultrasound may be used to assess the growth and development of the fetus, as well as to measure blood flow to the placenta. Reduced blood flow can be a sign of pre-eclampsia.
  5. Non-Stress Test: This test measures the baby’s heart rate in response to its movements. It helps assess the baby’s well-being and can detect any signs of distress, which may be related to pre-eclampsia.

These tests are typically performed at regular intervals throughout pregnancy, especially during the second and third trimesters. The results of the screening panel help healthcare providers determine the risk of developing pre-eclampsia and take appropriate measures to manage the condition.

Test Name PRE-ECLAMPSIA SCREENING PANEL Test
Components Early & late onset Pre-eclampsia Risk Assessment: * Placental Growth Factor (PlGF) * Pregnancy Associated Plasma Protein A (PAPP-A)
Price 700.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Test is valid between 10-13 weeks gestation.It is mandatory toprovide maternal Date of birth (dd\/mm\/yy); Height, weight, IVF, Smoking, History of blood pressure, Diabetes and Pre-eclampsia in previous pregnancy, Number of Fetuses (Single\/ Twins); Blood pressure measurement for right & left arm; USG for CRL & Uterine artery PI. Duly filled Pre-eclampsia screening form (Form 13) is mandatory.
Report Delivery Sample Tue / Thu / Sat by 9 am?? Report Same Day
Method ECLIA
Test type Pre-eclampsia
Doctor Gynecologist
Test Department: IMMUNOASSAY
Pre Test Information Duly filledPre-eclampsia screening form (Form 13) is mandatory. Test is valid between 10-13 weeks gestation.
Test Details

The pre-eclampsia screening panel is a set of tests conducted during pregnancy to assess the risk of developing pre-eclampsia, a condition characterized by high blood pressure and organ damage during pregnancy. The panel typically includes the following tests:

1. Blood Pressure Measurement: This is a standard test to monitor blood pressure levels throughout pregnancy. High blood pressure is one of the main symptoms of pre-eclampsia.

2. Urine Protein Test: This test measures the amount of protein present in the urine. Increased protein levels can indicate kidney damage, which is a common sign of pre-eclampsia.

3. Blood Tests: Various blood tests may be performed to evaluate liver and kidney function, as well as to assess blood clotting factors. Abnormalities in these tests can indicate pre-eclampsia.

4. Ultrasound: An ultrasound may be used to assess the growth and development of the fetus, as well as to measure blood flow to the placenta. Reduced blood flow can be a sign of pre-eclampsia.

5. Non-Stress Test: This test measures the baby’s heart rate in response to its movements. It helps assess the baby’s well-being and can detect any signs of distress, which may be related to pre-eclampsia.

These tests are typically performed at regular intervals throughout pregnancy, especially during the second and third trimesters. The results of the screening panel help healthcare providers determine the risk of developing pre-eclampsia and take appropriate measures to manage the condition.